Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
7(39%)
Results Posted
40%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph early_phase_1
1
6%
Ph not_applicable
17
94%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
N/ANon-phased studies
17(94.4%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

7

trials recruiting

Total Trials

18

all time

Status Distribution
Active(8)
Completed(5)
Terminated(1)
Other(4)

Detailed Status

Recruiting6
Completed5
unknown4
Terminated1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
7
Success Rate
83.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (5.6%)
N/A17 (94.4%)

Trials by Status

completed528%
terminated16%
unknown422%
recruiting633%
not_yet_recruiting16%
active_not_recruiting16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07608588Not Applicable

Recovery From Post-Stroke Aphasia With rTMS Targeting Left or Right Anterior Temporal Lobe

Recruiting
NCT06976840Not Applicable

Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments

Recruiting
NCT07580066Not Applicable

Cerebellum and Neglect

Not Yet Recruiting
NCT04798274Not Applicable

Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Recruiting
NCT05607121Not Applicable

TMS Visual Modulation in Body Dysmorphic Disorder

Completed
NCT05322239Not Applicable

Resting State Changes Following Theta Burst Stimulation

Recruiting
NCT07268001Not Applicable

Effects of Continuous Theta Burst Stimulation on Emotional Attention

Completed
NCT07267455Not Applicable

Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial

Recruiting
NCT07188376Not Applicable

Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation

Recruiting
NCT04846829Early Phase 1

Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)

Active Not Recruiting
NCT03737032Not Applicable

Theta Burst Stimulation in Young Adults With Depression

Completed
NCT03687892Not Applicable

Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation

Terminated
NCT05795088Not Applicable

Continuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's Disease

Unknown
NCT03984344Not Applicable

Theta Burst Stimulation in Anorexia Nervosa

Unknown
NCT04993144Not Applicable

The Therapeutic Effects of Continuous Theta Burst Stimulation in Autism Spectrum Disorder

Unknown
NCT03350087Not Applicable

Efficacy of rTMS and VCT on Upper Limb Function in Patients With Stroke

Unknown
NCT01947413Not Applicable

New Protocols in the Treatment of Upper Limb Dysfunctions of Patients With Stroke.

Completed
NCT01371409Not Applicable

Interhemispheric Inhibitory Interactions

Completed

All 18 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
18